comparemela.com

Latest Breaking News On - Kiernan lamarche - Page 1 : comparemela.com

04 01 22 -- Important cGMP Considerations For Implementing Electronic Batch Records

11 02 21 -- Explosion Of Start-Ups Underline Need For AI/ML

09 28 21 -- 3 Successful Strategies For Protecting Your New Biopharma s IP

09 28 21 -- 3 Successful Strategies For Protecting Your New Biopharma s IP
pharmaceuticalonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceuticalonline.com Daily Mail and Mail on Sunday newspapers.

Product Development For An Oral Solid Dosage Using Continuous Manufacturing

Product Development For An Oral Solid Dosage Using Continuous Manufacturing Source: Thermo Fisher Scientific By Kiernan LaMarche and Jessica Settimi, Thermo Fisher When bringing a new drug to market, product development is typically aligned with the clinical trial schedule; therefore, as the patient pool grows, so does the supply of drugs needed for the study. Phase I calls for a small trial formulation using the easiest and least expensive manufacturing methods for just getting the drug to the patient. Once you move into Phase II, a prototype batch process is often most cost effective, especially since most drug candidates do not make it past this stage.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.